FDA Inspection
Exela Pharma Sciences LLCExela Pharma Sciences LLC – FDA Inspection, Sep 11, 2018
Record Details
This FDA Inspection record concerns Exela Pharma Sciences LLC, with an inspection on September 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 04fb85de-d9ad-4cdf-b407-5e409c65b64c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1067755
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Exela Pharma Sciences LLC
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 15, 2024 | OAI | Drug Quality Assurance | |
| July 18, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 29, 2019 | VAI | Atlanta District Office | Generic Drug Evaluation |
| December 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 27, 2017 | Not classified | Atlanta District Office |
Other documents for Exela Pharma Sciences LLC
- FDA Inspection 1256957 - 2024-11-15
- FDA Inspection 1096634 - 2019-07-18
- FDA Inspection 1084304 - 2019-03-29
- FDA Inspection 1081405 - 2018-12-19
- FDA Inspection 1032076 - 2017-10-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.